Callan Family Office LLC Invests $436,000 in The Allstate Co. (NYSE:ALL)

Callan Family Office LLC purchased a new stake in shares of The Allstate Co. (NYSE:ALL - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 2,263 shares of the insurance provider's stock, valued at approximately $436,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Apella Capital LLC grew its position in Allstate by 1.9% in the fourth quarter. Apella Capital LLC now owns 3,231 shares of the insurance provider's stock worth $623,000 after acquiring an additional 60 shares in the last quarter. Avior Wealth Management LLC grew its position in Allstate by 4.9% in the third quarter. Avior Wealth Management LLC now owns 1,329 shares of the insurance provider's stock worth $252,000 after acquiring an additional 62 shares in the last quarter. Perigon Wealth Management LLC grew its position in Allstate by 2.1% in the fourth quarter. Perigon Wealth Management LLC now owns 2,990 shares of the insurance provider's stock worth $571,000 after acquiring an additional 62 shares in the last quarter. Mather Group LLC. grew its position in Allstate by 1.7% in the fourth quarter. Mather Group LLC. now owns 3,616 shares of the insurance provider's stock worth $697,000 after acquiring an additional 62 shares in the last quarter. Finally, Angeles Wealth Management LLC grew its position in Allstate by 4.6% in the fourth quarter. Angeles Wealth Management LLC now owns 1,403 shares of the insurance provider's stock worth $270,000 after acquiring an additional 62 shares in the last quarter. Institutional investors own 76.47% of the company's stock.

Allstate Stock Down 0.9 %

Shares of NYSE ALL traded down $1.73 during mid-day trading on Monday, hitting $199.00. 2,711,809 shares of the stock traded hands, compared to its average volume of 1,874,689. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.40 and a current ratio of 0.36. The Allstate Co. has a 52 week low of $156.45 and a 52 week high of $209.88. The company has a market cap of $52.74 billion, a price-to-earnings ratio of 11.71, a PEG ratio of 1.01 and a beta of 0.47. The stock has a fifty day moving average price of $190.76 and a 200-day moving average price of $191.82.

Remove Ads

Allstate (NYSE:ALL - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share for the quarter, beating the consensus estimate of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. Research analysts anticipate that The Allstate Co. will post 18.74 EPS for the current year.

Allstate announced that its board has approved a stock buyback program on Wednesday, February 26th that authorizes the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization authorizes the insurance provider to repurchase up to 3% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company's management believes its stock is undervalued.

Allstate Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 10th will be issued a $1.00 dividend. This represents a $4.00 annualized dividend and a yield of 2.01%. This is an increase from Allstate's previous quarterly dividend of $0.92. The ex-dividend date is Monday, March 10th. Allstate's payout ratio is 23.54%.

Insiders Place Their Bets

In other Allstate news, CFO Jesse E. Merten sold 40,102 shares of the business's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the sale, the chief financial officer now directly owns 18,115 shares of the company's stock, valued at approximately $3,378,990.95. The trade was a 68.88 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 1.80% of the company's stock.

Analysts Set New Price Targets

Several analysts have weighed in on the stock. Piper Sandler boosted their price target on shares of Allstate from $206.00 to $244.00 and gave the stock an "overweight" rating in a research note on Tuesday, November 26th. Wells Fargo & Company raised their price objective on Allstate from $186.00 to $187.00 and gave the company an "equal weight" rating in a research note on Tuesday, January 14th. Argus raised Allstate from a "hold" rating to a "buy" rating in a research note on Monday, March 3rd. Barclays reduced their price objective on Allstate from $187.00 to $183.00 and set an "underweight" rating on the stock in a research note on Monday, January 6th. Finally, Evercore ISI raised Allstate from an "in-line" rating to an "outperform" rating in a research note on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $217.94.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.